Ingredients

Beckley Psytech receives FDA approval for short-acting psychedelic

This is the first time the FDA has given IND approval for a Phase IIb study of a short-acting psychedelic like 5-MeO-DMT (Mebufotenin

Breaking News

Study reveals affects of low endotoxin biomaterials reliability in 3D in vitro models

The joint study done by the University of Twente, The Netherlands, and Rousselot Biomedical investigated for the first time the impact of endotoxin...

Beckley Psytech receives FDA approval for short-acting psychedelic

This is the first time the FDA has given IND approval for a Phase IIb study of a short-acting psychedelic like 5-MeO-DMT (Mebufotenin

Corbion awarded a 2023 EcoVadis gold medal for sustainability

The company’s overall sustainability performance for 2023 ranks among the top 2% of all audited suppliers in a wide range of industries globally T...

What does 2023 hold for oral solid dosage forms?

Recipharm’s Uwe Hanenberg, Head of Product Development, Oral Solid Dose, and Maria Lundin-Johnson, Head of Formulation Development, explore the lat...

Tickets now on sale for 2023 Manufacturing Chemist Live

Super early bird tickets are now on sale for the annual conference due to take place in Birmingham on 24 – 25 May 2023

Get ahead of the curve in 2023 with a subscription

Keep abreast of significant pharmaceutical developments around the world

The trend for customised raw materials and outsourced buffer manufacturing

Customisation in biopharmaceuticals usually comes into play when standard excipients with slightly different purity profiles are required. For exam...

FUJIFILM launches viral vector feed designed to increase yields

FUJIFILM Irvine Scientific has launched its BalanCD HEK293 Viral Feed designed to boost adeno-associated viral vector (AAV) production for gene the...

Brenntag becomes exclusive distributor for INOFEA services in EMEA

INOFEA has developed the enzzen technology, enhancing enzyme stability, enabling recyclability and easy recovery in manufacturing steps

Watch the webinar: Is CBD a promising therapy for mental health disorders?

In this webinar, which took place on 29 September, experts discuss the potential of CBD in early drug development for mental health disorders, and...

Orodispersibles and minitablets: optimising patient compliance by improving the sensory properties with isomalt

Orally dispersible minitablets are a drug dosage form that can help to improve patient compliance among children and others who have difficulty swa...

Catalent signs development deal with Ethicann for new fast-dissolve cannabinoid treatment

Catalent and Canadian/US cannabinoid drug therapy company Ethicann Pharmaceuticals have executed a development and license agreement that will use...

ExxonMobil expands healthcare product portfolio

The company is now focused on maximising performance and longevity for a range of medical supplies

CPHI Annual Report: Building a more resilient supply chain for excipients

Ahead of CPHI, which is back in Frankfurt this year from 1–3 November with visitor numbers expected to meet or exceed prepandemic levels, Iain Moor...

TriLink offers new GMP-grade material for mRNA manufacturing

N1-Methyl-Pseudouridine-5’-Triphosphate, a critical raw material for mRNA manufacturing, allows researchers to accelerate their drug discovery and...

What role can CBD play to support mental health?

Talking to Dr Kevin Robinson (KSR), DSM’s Clinical Project Scientist, Mariana Coelho (MC), shares the latest scientific findings behind CBD and how...